Review
Published on 06 Nov 2024
Chemical adherence testing in the clinical management of hypertension: a scoping review
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1452464
- 698 views
Type at least 3 characters
1,988 articles
Articles
Original Research
Published on 05 Nov 2024
The effect of cognitive emotion regulation on direct-acting antivirals adherence in patients with hepatitis C
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1369166
- 466 views
Editorial
Published on 05 Nov 2024
Editorial: Towards continued and affordable accessibility of innovative drugs: sustainable development and efficient use of medicines
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1490853
- 631 views
Original Research
Published on 05 Nov 2024
Evaluating nivolumab plus gemcitabine–cisplatin’s cost-effectiveness for aUC in China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1382342
- 597 views
Correction
Published on 31 Oct 2024
Corrigendum: Impact of a DSS-supported medication review on the safety of drug therapy and quality of life in patients with antithrombotic therapy
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1507320
- 256 views
Review
Published on 31 Oct 2024
Opioid-free strategies for patient-controlled intravenous postoperative analgesia: a review of recent studies
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1454112
- 639 views
Original Research
Published on 28 Oct 2024
Sequential versus concomitant treatment of androgen receptor signaling inhibitors and docetaxel for metastatic hormone-sensitive prostate cancer: an network meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1462360
- 895 views
Original Research
Published on 25 Oct 2024
Safety assessment of sapropterin dihydrochloride: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1486597
- 1,010 views
Brief Research Report
Published on 25 Oct 2024
Clinical risk factors of bevacizumab-related hypertension in patients with metastatic colorectal cancer: a retrospective study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1463026
- 551 views
Original Research
Published on 24 Oct 2024
Pharmacist-led hospital intervention reduces unintentional patient-generated medication discrepancies after hospital discharge
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1483932
- 535 views
Original Research
Published on 23 Oct 2024
Transforming respiratory diseases management: a CMO-based hospital pharmaceutical care model
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1461473
- 908 views
Original Research
Published on 21 Oct 2024
Atezolizumab plus bevacizumab and chemotherapy versus bevacizumab plus chemotherapy for metastatic cervical cancer: a cost-effectiveness analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1476256
- 747 views
Correction
Published on 17 Oct 2024
Corrigendum: Effectiveness of perindopril/amlodipine fixed-dose combination in the treatment of hypertension: a systematic review
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1485834
- 555 views
Clinical Trial
Published on 17 Oct 2024
Comparative analysis of the therapeutic efficacy of remimazolam tosylate and propofol in older adults undergoing painless endoscopic retrograde cholangiopancreatography
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1404536
- 698 views
Original Research
Published on 15 Oct 2024
Willingness to pay and price elasticity of demand for long-acting injectable cabotegravir among men who have sex with men in Guangxi, China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1367830
- 659 views
Original Research
Published on 15 Oct 2024
Drug-drug-interactions in patients with atrial fibrillation admitted to the emergency department
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1432713
- 977 views